Skip to main content
. 2018 Jan 23;8:1420. doi: 10.1038/s41598-018-19300-6

Figure 7.

Figure 7

Anti-tumour effects of oncolytic adenoviruses in an orthotopic glioblastoma tumour model. Orthotopic brain tumour model was established by stereotaxically implanting U87MG cells into the left forebrain of nude mice. Seven days after tumour cell injection, PBS, H5CmTERT-Rd19-Ad, or H5CmTERT-Ad/TRAIL (5 × 109 VPs) were administered via intracranial injection. (a) At 17 days after the cell injection, the mice were euthanised and the brains were collected. Representative tissue slices were stained with H & E to assess the tumour burden in each treatment group in the ImageJ software. Original magnification: ×100. *P < 0.05, **P < 0.01, ***P < 0.001. (b) The expression levels of TRAIL and E1A were assessed by immunohistochemistry. A TUNEL assay was carried out to detect apoptosis. Original magnification: ×400. (c) Semi-quantitative analysis of TRAIL-, E1A-, or TUNEL-stained sections using MetaMorph image analysis software. Images are representative of three independent experiments. All results are shown as mean ± SD; *P < 0.05, **P < 0.01, ***P < 0.001.